Sovenyr
Get early access
Signal
2026-07-07
ClinicalTrials.gov
[PHASE2] Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanced Esophageal Squamous Cell Carcinoma, Phase II
Part of
Molecular Profiling In Endocrine Neoplasms
Open primary source
See the whole picture